What does a contract fermentation manufacturer actually do?

Stijn Boeren · 02 Oct 2026

A contract fermentation manufacturer is a specialist partner that runs microbial fermentation processes on behalf of another company, using its own infrastructure, expertise, and analytical tools. Rather than building and staffing a fermentation facility internally, a company hands off part or all of its process development to an external team that already has the reactors, the know-how, and the regulatory framework in place. The sections below address the most common questions companies ask before entering a contract fermentation arrangement.

What services does a contract fermentation manufacturer provide?

A contract fermentation manufacturer provides end-to-end support for microbial fermentation processes, from early-stage feasibility testing through pilot-scale validation and into small-scale commercial production. The scope typically covers process design, bioreactor operation, downstream processing, and scientific reporting, all delivered using the manufacturer’s own infrastructure.

In practice, the service portfolio usually breaks down into three layers. The first is lab-scale feasibility work: testing whether a given microbial system can produce the target compound or perform the desired bioconversion under controlled conditions. The second layer is pilot-scale process development, where parameters identified at lab scale are transferred to larger reactors, stress-tested, and optimized for robustness. The third layer is contract production, where a validated process is run repeatedly to deliver batches of a microbial product for commercial or regulatory purposes.

Beyond reactor operation, a capable microbial fermentation service provider also handles downstream processing steps such as centrifugation, pasteurization, and drying, as well as quality documentation and analytical monitoring throughout the run. Scientific reporting is often included, which matters when clients need to support grant applications, patent filings, or investor due diligence.

How does the scale-up process work in contract fermentation?

Scale-up in contract fermentation moves through defined stages: lab-scale screening, bench-scale optimization, pilot-scale validation, and then production-scale transfer. Each stage is designed to understand and control the process variables that change when reactor volume increases, so that performance at small scale is reliably reproduced at larger volumes.

The most common failure point in fermentation scale-up is the assumption that what works in a shake flask or a 5-liter bench reactor will behave identically in a 500-liter pilot vessel. It will not. Mixing dynamics, oxygen transfer rates, heat dissipation, and pH gradients all shift as volume increases. A contract fermentation partner with genuine pilot-scale infrastructure can identify these shifts systematically rather than discovering them after a failed production run.

A structured scale-up process typically follows this sequence:

Lab-scale screening — identify the microbial system, key substrates, and critical process parameters
Bench-scale optimization — refine temperature, pH, aeration, feeding strategy, and inoculum conditions
Pilot-scale validation — transfer the optimized protocol to a larger bioreactor and confirm reproducibility
Process documentation — record all parameters and deviations to build a transferable process description

Fermentation scale-up is rarely linear. A reliable contract partner treats each transition as a hypothesis to be tested, not a box to be ticked.

Get in Touch

Let’s Talk Microbial Solutions

Book a conversation with Stijn, our CEO, or send us your request.

Book an Appointment

Request Information

What’s the difference between pure culture and mixed microbial culture fermentation?

Pure culture fermentation uses a single, well-characterized microbial strain, often genetically modified, to perform a specific conversion. Mixed microbial culture fermentation uses a community of naturally occurring microorganisms that work together, with the process steered rather than controlled at the strain level. Both approaches have legitimate industrial applications, but they suit different problems.

Pure cultures offer predictability and tight product specificity. They are the standard in pharmaceutical fermentation and wherever regulatory frameworks require a defined, traceable organism. The trade-off is fragility: a pure culture is vulnerable to contamination, requires sterile conditions throughout, and can fail entirely if the strain drifts or a competitor organism enters the system.

Mixed microbial communities are inherently more robust. Because multiple species share the metabolic workload, the community can tolerate fluctuations in feedstock composition, temperature, and pH that would destabilize a pure culture. This makes mixed cultures particularly well-suited to processing complex or variable industrial streams, such as food processing side streams or agricultural residues, where feedstock consistency cannot be guaranteed.

Avecom’s founding philosophy is built on the value of engineered mixed microbial communities, a deliberate counterpoint to the industry’s dominant focus on pure and genetically modified strains. For many industrial fermentation applications, a well-steered mixed culture delivers comparable or superior performance at lower operational cost and without the regulatory burden associated with GMO organisms.

When should a company use a contract fermentation partner instead of building in-house?

A company should use a contract fermentation partner when the cost, time, or risk of building internal fermentation infrastructure outweighs the strategic benefit of owning it. For most companies at the concept validation or early scale-up stage, contracting out is faster, cheaper, and technically safer than constructing and staffing a dedicated facility.

The clearest signals that a contract partner is the right choice include:

The internal lab is equipped for chemistry or biology but not for controlled bioreactor work at pilot scale
Investors or customers require a proof of concept within 6 to 12 months — a timeline that makes building infrastructure impractical
The fermentation process is novel enough that internal expertise does not yet exist
The company needs a validated process description for a patent application or regulatory submission
Production volumes are too low to justify the capital expenditure of a dedicated facility

Building in-house makes sense when fermentation is genuinely core to the business model, volumes are high enough to absorb fixed costs, and the company has or can hire the specialized technical staff to operate and maintain the equipment. For most biotech scale-ups and ingredient producers, that threshold is further away than it initially appears.

What analytical capabilities should a contract fermentation manufacturer have?

A contract fermentation manufacturer should have analytical capabilities that go beyond basic process monitoring. In addition to standard parameters like pH, dissolved oxygen, temperature, and biomass concentration, a serious partner will have access to molecular tools that characterize the microbial community itself, not just the bulk process metrics.

For mixed culture processes in particular, the ability to monitor community composition over time is critical. Amplicon sequencing allows identification of which microbial taxa are present and in what proportions. Quantitative PCR (qPCR) enables targeted tracking of specific organisms or functional genes. Together, these tools allow a contract partner to detect community shifts early, diagnose process instability, and make informed adjustments before a batch is compromised.

On the product side, analytical capabilities should cover whatever the client’s output requires: protein content, metabolite profiles, contaminant screening, or viability counts, depending on the application. The ability to generate defensible analytical data is also important when results need to support grant applications, patent claims, or regulatory submissions.

How does intellectual property work in a contract fermentation arrangement?

In a contract fermentation arrangement, intellectual property ownership is governed by the agreement between the client and the manufacturer, not by default rules. The standard expectation is that the client retains ownership of the process concept, any novel strains or formulations they bring in, and any results generated during the project. The contract manufacturer contributes its infrastructure, know-how, and analytical services but does not acquire rights to the client’s IP simply by running the process.

In practice, IP arrangements in contract fermentation need to address several distinct categories:

Background IP — knowledge, tools, and methods each party brings into the project. These remain the property of the originating party.
Foreground IP — new inventions or discoveries arising from the project. Ownership should be agreed in advance: solely with the client, jointly, or with a licensing arrangement.
Confidentiality — the contract manufacturer should operate under a non-disclosure agreement that covers process details, feedstock compositions, and results.

Companies working with a contract fermentation partner for the first time often underestimate how important it is to define these boundaries before work begins. A manufacturer with genuine scientific depth will be able to contribute ideas and optimizations during a project, and without clear IP terms, the ownership of those contributions can become ambiguous. A well-structured agreement protects both parties and makes it easier to file patents or approach investors with a clean IP position once the project concludes.